Erenumab was not effective in reducing pain intensity in patients with trigeminal neuralgia, researchers reported in Lancet Neurology.
Trigeminal neuralgia is a severe facial pain disorder that is difficult to treat. It is the most common facial pain neuralgia, and there are currently no treatments for the disorder, Anne Sofie Schott Andersen, MD, of the Danish Headache Center at Copenhagen University in Denmark, and colleagues wrote.
Andersen and colleagues conducted a randomized, double-blind, placebo-controlled trial in adults aged 18 to 85 years with idiopathic classic trigeminal neuralgia